Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.
about
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifeneMetabolic effects of contraceptive steroidsEffects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism.Intravenous estrogens increase insulin clearance and action in postmenopausal women.Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.Aspects of the treatment of Turner syndrome.Menopause, energy expenditure, and body composition.How progestins influence the cardiovascular effect of hormone replacement therapy.The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?Sex hormones, insulin sensitivity, and diabetes mellitus.Consequences of menopause in women with diabetes mellitus - a clinical problem.Insulin secretion and clearance after subacute estradiol administration in postmenopausal womenNew concepts in diabetes mellitus. I: Treatment, pregnancy and aetiologyEffect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion.Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.Effects of Hormone Replacement Therapy on Insulin Resistance in Postmenopausal Diabetic Women.Differential effects of various progestogens on metabolic risk factors for breast cancer.Review and Recommendations on Management of Adult Female Thalassemia Patients with Hypogonadism based on Literature Review and Experience of ICET-A Network Specialists.Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.Women at cardiac risk: is HRT the route to maintaining cardiovascular health?Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women.The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.Estradiol does not directly regulate adipose lipolysis.Menopause, Estrogens, and Glucose Homeostasis in Women.Melatonin supplementation therapy as a potent alternative to ERT in ovariectomized rats.Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.Risk of breast cancer during hormone replacement therapy: mechanisms.
P2860
Q26751149-9BB292C6-AE79-4047-B609-EC9D90ED458FQ28236638-ED7AAA83-6B84-4F31-8396-93F2DD8053E9Q32026925-3B89BA5F-4F08-46A7-9EC0-1073F2B28D86Q33643819-4BE65118-ACF3-4E29-8233-311158BB797FQ34420425-67D86097-ACA4-47F7-9CDE-61A1564A760FQ34515414-3321671C-4C90-4A71-8A56-88EFA329E07DQ34792332-6B4406E5-3B42-463C-BAE1-0C5496BC26D8Q34847431-777DD252-9FFF-4675-82D9-0D109C5245D0Q34932849-4B577C0F-ACBB-4845-9670-8A268A2D7FB6Q35757562-B466C431-B9E6-4861-BA38-B4B388B12CA1Q36350792-899ED830-A47B-4B92-B59B-67F2EE91B962Q36459951-7E8C67D5-57F3-4A89-83E7-2FBF9C8FF79BQ36679153-715F1549-A34D-4EFE-B6F6-03A45B9515F6Q36732072-F8667687-9721-4429-905A-51863E9B3E87Q36836702-ADC02B26-7004-4497-9C21-C06DBF0BCA71Q36945045-8C00D935-1129-4730-84DC-E40BD04A5175Q36974417-37F617E2-F4E4-4F66-85A2-0785A0A0DCD3Q37577867-6A6DA723-90F2-48D1-BEF5-D49927F4A808Q39190439-92DD011C-76D8-4A2C-91EC-3211C4EDAB2EQ40436937-0F107646-6F23-4416-AD17-BB2799BE1E17Q40496635-04A7905B-6805-4DBB-9A0C-1E8BC22C9708Q41654083-A7FFC2AD-CEB0-488E-9CB5-913A6EB64944Q44704999-77876C5B-5446-47B2-8474-4732DE9FBA32Q44791857-E2EF1D9D-E9CB-4426-A3B4-BC5B7DEF7B50Q44856184-41A438A5-86D3-4B23-9733-BA604FFFC65EQ46259264-69937706-6341-4A4E-A1E9-461DF286FCD3Q46515516-E443918E-7DB6-4E61-8629-511D98E08833Q48048557-DF505C02-51B5-4615-9DD1-3D521DB87134Q49193164-3BFF142E-8C05-4147-B468-929EBDC4A57AQ49971631-0ADE8AF1-746E-4084-91F0-1DF420C7B89AQ51363689-9566EC1F-23C1-48B1-9642-49E337ACE404Q51544028-C0E253F0-6A1D-4F30-A877-C4BE26928F5AQ53292939-1C827B69-2AC2-4F4C-9DA6-C1173F83913B
P2860
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Insulin resistance, secretion, ...... l hormone replacement therapy.
@en
Insulin resistance, secretion, ...... l hormone replacement therapy.
@nl
type
label
Insulin resistance, secretion, ...... l hormone replacement therapy.
@en
Insulin resistance, secretion, ...... l hormone replacement therapy.
@nl
prefLabel
Insulin resistance, secretion, ...... l hormone replacement therapy.
@en
Insulin resistance, secretion, ...... l hormone replacement therapy.
@nl
P2093
P1433
P1476
Insulin resistance, secretion, ...... al hormone replacement therapy
@en
P2093
I F Godsland
J C Stevenson
M I Whitehead
P304
P356
10.1016/0026-0495(93)90058-V
P50
P577
1993-07-01T00:00:00Z